1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
4
|
Johnson M, Sharma M and Henderson BR:
IQGAP1 regulation and roles in cancer. Cell Signal. 21:1471–1478.
2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Noritake J, Watanabe T, Sato K, Wang S and
Kaibuchi K: IQGAP1: A key regulator of adhesion and migration. J
Cell Sci. 118:2085–2092. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
White CD, Erdemir HH and Sacks DB: IQGAP1
and its binding proteins control diverse biological functions. Cell
Signal. 24:826–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nabeshima K, Shimao Y, Inoue T and Koono
M: Immunohistochemical analysis of IQGAP1 expression in human
colorectal carcinomas: Its overexpression in carcinomas and
association with invasion fronts. Cancer Lett. 176:101–109. 2002.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Hayashi H, Nabeshima K, Aoki M, Hamasaki
M, Enatsu S, Yamauchi Y, Yamashita Y and Iwasaki H: Overexpression
of IQGAP1 in advanced colorectal cancer correlates with poor
prognosis-critical role in tumor invasion. Int J Cancer.
126:2563–2574. 2010.PubMed/NCBI
|
9
|
Jadeski L, Mataraza JM, Jeong HW, Li Z and
Sacks DB: IQGAP1 stimulates proliferation and enhances
tumorigenesis of human breast epithelial cells. J Biol Chem.
283:1008–1017. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Dong P, Nabeshima K, Nishimura N, Kawakami
T, Hachisuga T, Kawarabayashi T and Iwasaki H: Overexpression and
diffuse expression pattern of IQGAP1 at invasion fronts are
independent prognostic parameters in ovarian carcinomas. Cancer
Lett. 243:120–127. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhao H, Xie C, Lin X, Zhao Y, Han Y, Fan
C, Zhang X, Du J, Han Y, Han Q, et al: Coexpression of IQ-domain
GTPase-activating protein 1 (IQGAP1) and Dishevelled (Dvl) is
correlated with poor prognosis in non-small cell lung cancer. PLoS
One. 9:e1137132014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang XX, Li XZ, Zhai LQ, Liu ZR, Chen XJ
and Pei Y: Overexpression of IQGAP1 in human pancreatic cancer.
Hepatobiliary Pancreat Dis Int. 12:540–545. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu Z, Liu D, Bojdani E, El-Naggar AK,
Vasko V and Xing M: IQGAP1 plays an important role in the
invasiveness of thyroid cancer. Clin Cancer Res. 16:6009–6018.
2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang XX, Wang K, Li XZ, Zhai LQ, Qu CX,
Zhao Y, Liu ZR, Wang HZ, An QJ, Jing LW, et al: Targeted knockdown
of IQGAP1 inhibits the progression of esophageal squamous cell
carcinoma in vitro and in vivo. PLoS One. 9:e965012014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Arnaoutova I, George J, Kleinman HK and
Benton G: The endothelial cell tube formation assay on basement
membrane turns 20: State of the science and the art. Angiogenesis.
12:267–274. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ponce ML: Tube formation: An in vitro
matrigel angiogenesis assay. Methods Mol Biol. 467:183–188. 2009.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Ribatti D, Vacca A, Roncali L and Dammacco
F: The chick embryo chorioallantoic membrane as a model for in vivo
research on angiogenesis. Int J Dev Biol. 40:1189–1197.
1996.PubMed/NCBI
|
18
|
Verheul HM and Pinedo HM: The role of
vascular endothelial growth factor (VEGF) in tumor angiogenesis and
early clinical development of VEGF-receptor kinase inhibitors. Clin
Breast Cancer. 1 Suppl 1:S80–S84. 2000. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zetter BR: Angiogenesis and tumor
metastasis. Annu Rev Med. 49:407–424. 1998. View Article : Google Scholar : PubMed/NCBI
|
20
|
Osman M: An emerging role for IQGAP1 in
regulating protein traffic. ScientificWorldJournal. 10:944–953.
2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
White CD, Brown MD and Sacks DB: IQGAPs in
cancer: A family of scaffold proteins underlying tumorigenesis.
FEBS Lett. 583:1817–1824. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Detmar M: Tumor angiogenesis. J Investig
Dermatol Symp Proc. 5:20–23. 2000. View Article : Google Scholar : PubMed/NCBI
|
23
|
Shibuya M: Vascular endothelial growth
factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A
crucial target for anti- and pro-angiogenic therapies. Genes
Cancer. 2:1097–1105. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
McMahon G: VEGF receptor signaling in
tumor angiogenesis. Oncologist. 5 Suppl 1:S3–S10. 2000. View Article : Google Scholar
|
25
|
Yamaoka-Tojo M, Tojo T, Kim HW, Hilenski
L, Patrushev NA, Zhang L, Fukai T and Ushio-Fukai M: IQGAP1
mediates VE-cadherin-based cell-cell contacts and VEGF signaling at
adherence junctions linked to angiogenesis. Arterioscler Thromb
Vasc Biol. 26:1991–1997. 2006. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yamaoka-Tojo M, Ushio-Fukai M, Hilenski L,
Dikalov SI, Chen YE, Tojo T, Fukai T, Fujimoto M, Patrushev NA,
Wang N, et al: IQGAP1, a novel vascular endothelial growth factor
receptor binding protein, is involved in reactive oxygen
species-dependent endothelial migration and proliferation. Circ
Res. 95:276–283. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Meyer RD, Sacks DB and Rahimi N:
IQGAP1-dependent signaling pathway regulates endothelial cell
proliferation and angiogenesis. PLoS One. 3:e38482008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Jiang BH and Liu LZ: AKT signaling in
regulating angiogenesis. Curr Cancer Drug Targets. 8:19–26. 2008.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Dhillon AS, Hagan S, Rath O and Kolch W:
MAP kinase signalling pathways in cancer. Oncogene. 26:3279–3290.
2007. View Article : Google Scholar : PubMed/NCBI
|
31
|
Ding C, Li L, Yang T, Fan X and Wu G:
Combined application of anti-VEGF and anti-EGFR attenuates the
growth and angiogenesis of colorectal cancer mainly through
suppressing AKT and ERK signaling in mice model. BMC Cancer.
16:7912016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Sbroggiò M, Carnevale D, Bertero A,
Cifelli G, De Blasio E, Mascio G, Hirsch E, Bahou WF, Turco E,
Silengo L, et al: IQGAP1 regulates ERK1/2 and AKT signalling in the
heart and sustains functional remodelling upon pressure overload.
Cardiovasc Res. 91:456–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
33
|
Chen F, Zhu HH, Zhou LF, Wu SS, Wang J and
Chen Z: IQGAP1 is overexpressed in hepatocellular carcinoma and
promotes cell proliferation by Akt activation. Exp Mol Med.
42:477–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ma Y, Jin Z, Huang J, Zhou S, Ye H, Jiang
S and Yu K: IQGAP1 plays an important role in the cell
proliferation of multiple myeloma via the MAP kinase (ERK) pathway.
Oncol Rep. 30:3032–3038. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Cheung KL, Lee JH, Shu L, Kim JH, Sacks DB
and Kong AN: The Ras GTPase-activating-like protein IQGAP1 mediates
Nrf2 protein activation via the mitogen-activated protein
kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)-ERK
pathway. J Biol Chem. 288:22378–22386. 2013. View Article : Google Scholar : PubMed/NCBI
|